INTRODUCTION
Trypanosoma brucei is the protist parasite responsible for the fatal human disease human African trypanosomiasis (HAT) and a related disease in livestock called nagana. The few current pharmacological options to treat HAT are hampered by high toxicity and the emergence of drug resistant parasites (
1). Therefore, there is an urgent need for the development of new drugs. Trypanosomes possess a number of biological features without counterparts in humans that may provide sources of new targets for drug discovery efforts. One of the parasite's most remarkable properties is the unusual mitochondrial DNA network of trypanosomatids called kinetoplast DNA (kDNA). This DNA network is housed within the parasite's single mitochondrion and contains topologically interlocked circular DNA molecules called minicircles and maxicircles (
43). Maxicircles are functionally similar to other eukaryotic mitochondrial DNA in that they encode proteins involved in respiratory complexes (
13). Nascent maxicircle transcripts require insertion and deletion of uridines in order to create a functional open reading frame (
16). This posttranscriptional process, known as RNA editing, is dependent upon minicircle-encoded guide RNAs (
16,
45). Therefore, both minicircles and maxicircles are essential for mitochondrial physiology.
The topological complexity of the catenated kDNA network dictates a unique mode of replication in which minicircles are released from the network, replicated as theta structures, and reattached to the network periphery where Okazaki fragment processing occurs (
43). A plethora of proteins involved in kDNA replication have been studied in
T. brucei, including six helicases (
25–
27,
40), two DNA ligases (
10), two primases (
19,
20), a topoisomerase IA (
40), a topoisomerase II (
50), and five DNA polymerases (Pols) (
4,
7,
21,
35). The involvement of multiple DNA polymerases in kDNA replication distinguishes this process from replication of other mitochondrial genomes, which depend solely upon DNA polymerase γ, a family A DNA polymerase. In
T. brucei, Pol β and Pol β PAK (two mitochondrial family X DNA polymerases) contribute to Okazaki fragment processing and gap filling in the later stages of minicircle replication (
35). The mitochondrial localization of the Pol β enzymes in
T. brucei is in contrast to other eukaryotes, where Pol β enzymes participate in nuclear DNA repair. The three other mitochondrial DNA polymerases of
T. brucei (POLIB, POLIC, and POLID) are family A proteins that are most related to prokaryotic DNA polymerase I and appear to function in the earlier stages of kDNA replication, each with a specialized function (
4,
7,
21). POLIB, POLIC, and POLID lack homologues in mammals, including humans, thus identifying these proteins as potential biological targets for the development of new antitrypanosomal drugs. Analyses of kDNA replication proteins have provided compelling molecular evidence for essential functions in distinct steps of kDNA replication in procyclic form (PF) parasites, a life cycle stage found in its insect vector (
4,
7,
20,
26). However, analysis of kDNA replication protein functions in bloodstream form (BF) parasites, the life cycle stage found in the mammalian host and the target for disease intervention (
18,
37), is an understudied area of trypanosome biology.
A striking feature of
T. brucei is its ability to adapt to diverse environments encountered throughout the stages of its life cycle. Developmental regulation of mitochondrial activity appears to play a central role in these adaptations (
18,
30). PF parasites each possess a highly active, branched mitochondrion and generate ATP through oxidative phosphorylation and mitochondrial substrate-level phosphorylation (
47). Conversely, BF parasites each have a much-reduced mitochondrion, lack cytochromes, and depend exclusively upon glycolysis for ATP production. A strictly glycolytic metabolism creates a seeming independence of BF parasites from maxicircle-encoded products and contributed to the assumption that kDNA is dispensable in the BF stage, thus diminishing the value of kDNA replication proteins as a source of new drug targets. This notion has been challenged by multiple lines of evidence, beginning with the demonstration that RNA editing is active and essential in BF parasites and that maxicircle-encoded subunit A6 of the ATP synthase complex (complex V) is required for generation of the mitochondrial membrane potential (ΔΨm) (
14,
37,
39). More recently, mitochondrial translation was found to be essential for BF
T. brucei (
9). Further, inhibition of minicircle replication initiation appears to contribute to the trypanosome death elicited by treatment of infected animals with ethidium bromide (
34). These findings suggest that kDNA is by no means dispensable in this medically relevant life cycle stage.
Only a single kDNA replication protein, topoisomerase II (TbTopoII
mt), has been examined in BF
T. brucei thus far. RNA interference (RNAi) resulted in a modest loss of kDNA networks (20 to 30%) accompanied by slowed parasite growth but not cell death (
48,
53). The kDNA loss phenotype produced in BF parasites was significantly reduced compared to that produced in PF parasites, where TbTopoII
mt RNAi resulted in loss of kDNA in ∼80% of the population (
50). Silencing efficiency was not reported in these BF studies. Thus, it remains unclear if the slow-growth phenotype reflected a diminished requirement for this kDNA replication protein in BF parasites or an inefficient knockdown that makes data interpretation difficult. Nonetheless, these data could indicate that TbTopoII
mt is crucial for BF survival and strongly suggest that kDNA replication proteins are indeed required for viability of BF parasites.
We directly examined this hypothesis by individually silencing the family A mitochondrial DNA polymerases POLIB, POLIC, and POLID in BF parasites. Our previous studies of these polymerases indicated that all three are required for cell growth and revealed nonredundant roles in PF kDNA replication but did not encompass studies in BF parasites (
4,
7,
21). Here we report that depletion of these proteins was lethal to BF parasites and resulted in loss of kDNA networks. Network loss appeared to result from inhibition of minicircle replication and was accompanied by depolarization of mitochondrial membrane potential and subsequent parasite death. These findings provide the first direct evidence that BF parasites require kDNA replication for viability. Therefore, kDNA replication proteins warrant further investigation as biological targets for the development of new antitrypanosomal drugs.
DISCUSSION
Individual silencing experiments for three mitochondrial DNA polymerases, POLIB, POLIC, and POLID, have previously revealed essential kDNA replication roles in the PF insect stage of the parasite. This stage relies on maxicircle-encoded proteins for its oxidative phosphorylation metabolism. Alternatively, the metabolism of the disease-causing BF stage of the parasite is exclusively glycolytic (
12,
47). Therefore, the loss of kDNA would be lethal to BF parasites only if the kDNA-encoded proteins function in cellular processes besides oxidative phosphorylation. Recent studies indicate that RNA editing proteins, the A6 subunit of ATP synthase, and mitochondrial translation are essential in BF trypanosomes (
9,
37). However, silencing of TbTopoII
mt, the enzyme involved in reattaching newly synthesized minicircles to the network, in BF parasites resulted in only mild growth and kDNA loss defects. The goal of this study was to determine whether kDNA replication proteins were essential for BF parasite viability. Here we report the rapid loss of kDNA networks upon silencing of POLIB, POLIC, and POLID, and for each polymerase, loss of kDNA was followed by cell death. This marks the first time that ablation of kDNA replication proteins results in the lethality of BF
T. brucei.
Knockdown of each polymerase gene resulted in cell death 5 to 6 days post-RNAi induction (
Fig. 1). This likely indicates that loss of essential proteins encoded by kDNA (such as ATP synthase subunit A6), rather than depletion of enzymes required for its replication, is the primary cause of cell death. Proper mitochondrial function is required for numerous processes critical to cell physiology, including energy metabolism, calcium homeostasis and signaling, and generation of membrane potential (
3). This creates an attractive paradigm in which inhibition of a single kDNA replication enzyme could lead to the disruption of multiple essential cellular pathways, effectively creating a multipotent effect from inhibiting a single target. Maintenance of the mitochondrial membrane potential is clearly among these pathways, as we demonstrate here with membrane potential collapse beginning when POLIB-depleted parasites have lost more than 80% of minicircle and maxicircle mass (
Fig. 6). Loss of kDNA produced in response to ablation of other kDNA replication proteins in BF parasites would likely lead to a similar depolarization of membrane potential and subsequent parasite death. Yet unknown functions for kDNA-encoded proteins likely exist and may also prove to be essential in BF parasites. Alternative editing of maxicircle transcripts is hypothesized to increase mitochondrial protein diversity (
33). Indeed, AEP1, a product of alternative editing of cytochrome oxidase III, was identified as a kDNA maintenance factor in BF
T. brucei (
32). Additionally, a maxicircle coding sequence contains three “maxicircle unidentified reading frames” (MURFs) and a series of GC-rich regions predicted to encode a series of highly hydrophobic proteins of unknown function (
38). A more complete understanding of these components and the repertoire of proteins produced by alternative editing of maxicircle transcripts may reveal additional indispensable functions of kDNA-encoded components for BF parasites.
Our current functional analyses of the kDNA replication proteins POLIB, POLIC, and POLID indicate that the essential roles of these proteins in kDNA replication appear consistent in both life cycle stages examined. Silencing each of the polymerases resulted in loss of kDNA networks and was accompanied by changes in the repertoire of free minicircle species. For example, when silencing POLIB, unreplicated CC monomers persisted and fraction U accumulated, with the BF results indistinguishable from those obtained when silencing POLIB in PF parasites (
Fig. 5). Additionally, the kinetics of kDNA loss for POLIB and POLID were nearly identical, again similar to the results obtained from the PF silencing experiments. Interestingly, when comparing the rate of kDNA loss, however, the BF parasites appear to lose their kDNA with faster kinetics. While it took nearly 20 doublings for cells to lose their kDNA in PF POLIB silencing (52% with no kDNA, 40% with small kDNA), it took only 12 generations for BF parasites to lose their kDNA (90% with no kDNA). Currently we do not understand why kDNA loss occurs more rapidly in BF parasites, but life stage-specific cell cycle checkpoints have been identified and may contribute to these differences (
17).
This study is the first in-depth analysis of kDNA replication protein function in BF parasites. Previous functional studies of kDNA replication proteins have been performed in PF parasites, including those from our laboratory, yet the relevance of these analyses to drug development mandates essential function in disease-causing BF parasites. Focus on the PF stage is largely the result of highly efficient stable transfection methods for this form of the parasite. While standard transfection methodologies yield efficiencies of 10
−3 to 10
−6 in PF
T. brucei, the technique is remarkably less successful in BF parasites (10
−7 to 10
−8) (
6,
23,
29,
46). However, the recent application of nucleofection to BF parasites increased stable transformation efficiency nearly 1,000-fold, providing greater opportunity to examine kDNA replication protein function in this disease-causing life cycle stage (
5). When silencing the three DNA polymerases, we found that parasites that survived RNAi (proliferated in clonogenic assays) still contained intact kDNA networks and remained responsive to induction for RNAi, as evidenced from growth kinetics and loss of kDNA during RNAi (
Fig. 4; see also Fig. S1 in the supplemental material). Sustained sensitivity to induction for RNAi is noteworthy here, since RNAi-resistant “revertant” parasites have been widely reported in both PF and BF
T. brucei (
8,
15,
22,
30,
31,
49). The reasons why revertants were not produced when silencing POLIB, POLIC, or POLID is beyond the scope of our analyses. Sustained RNAi sensitivity, however, was critical in determining the essential contribution that each of these mitochondrial DNA polymerases makes to the viability of BF
T. brucei.
The demonstration that BF
T. brucei cannot survive without kDNA is fundamental in evaluating kDNA replication proteins as drug targets. Yet, trypanosomes lacking functional portions of their kDNA genome exist in nature and have been generated through prolonged culture in the presence of mutagenic conditions (
38,
44). Isolates of naturally occurring dyskinetoplastid trypanosomes (
T. evansi and
T. equiperdum) vary in regards to the abundance and identity of residual minicircles and maxicircles (
38). Although permissive in these BF parasites, partial loss of kDNA locks the parasite into a monomorphic life cycle that is unable to survive in the tsetse fly vector and, therefore, spread from an infected host (
28,
36). Naturally dyskinetoplastid
T. equiperdum and
T. evansi, as well as an acriflavine-induced dyskinetoplastid strain of
T. brucei, were recently found to possess mutations in the nuclear encoded γ subunit of the ATP synthase complex. These mutations are proposed to compensate for the loss of maxicircle-encoded subunit A6 of this complex (
28,
36,
37). The compound ethidium bromide inhibits kDNA replication in BF parasites, yet viable dyskinetoplastid
T. brucei has not emerged despite decades of the compound's use in treating infected animals, suggesting that compensatory nuclear mutations occur at a low frequency (
34). Additionally, RNAi of other proteins required for kDNA function (particularly RNA editing) fails to produce viable dyskinetoplastid parasites (
39). Chemical inhibitors of kDNA replication proteins would likely inactivate target proteins even more rapidly than RNAi, thus decreasing the window of time for selection of these low-frequency mutations.
Our current study adds to a rapidly growing body of literature indicating that kDNA is required for BF mitochondrial physiology and, thus, viability. Indeed, two available treatments for sleeping sickness, pentamidine (in humans) and ethidium bromide (in livestock), appear to target kDNA (
34,
41). The historical success of drugs targeting kDNA and our finding that mitochondrial DNA polymerases IB, IC, and ID are essential in BF parasites indicate that targeting kDNA replication proteins remains a promising approach for the discovery of new antitrypanosomal drugs.